PharmaGossip

Alnylam Pharmaceuticals Inc. reports that its Phase 2 clinical trial of an RNA-interference (RNAi) drug for a respiratory disorder showed "significant" anti-viral activity.

Dr. John Bauer has been selected as the new president and chief executive officer of Bethesda Lutheran Homes and Services Inc. of Watertown.

Greater use of generic drugs dramatically slowed the growth in prescription drug costs last year, saving an estimated $5.2 billion for commercially insured Americans and benefit plan sponsors, according to a study of Express Scripts' clients released Friday.

Belden's board of directors appointed Mary McLeod as a director and member of the board's compensation committee, Belden announced Thursday. (PFE) (BDC)

The U.S. Navy has exercised an option on a previously awarded contract with Battelle subsidiary Bluefin Robotics Corp. for an autonomous underwater vehicle.